JDA 2022
DEL 2 AL 5 DE JUNIO DE 2022, KYOTO

 

Congreso de la Japanese Dermatological Association

 

Spesolimab treatment improves CGI scores via the JDA severity index in patients with GPP

Okubo Y, et al. Póster p16-6
 

   Descargar póster

 

SPE1167.11.2022